bg
A

Anaptysbio (ANAB)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Anaptysbio (ANAB)

AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its ... Read more

  • USD25.43
  • USD25.43
  • USD24.51
  • USD27.50
  • 16.80%
  • 23M
  • 190.84k
  • 392.21k
  • 640M
  • 13.36
  • 31.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.